Lawyers to Meet Next Week on Merck's Vioxx -NYT
102650
Drugs giant Merck & Co. which pulled its blockbuster painkiller Vioxx from shelves in September, is about to become the target of hundreds of plaintiffs' lawyers, the New York Times reported on Friday.
182282
In New York, the blue-chip Dow Jones average fell on Thursday after drug maker Merck &amp; Co withdrew its widely used Vioxx painkiller after evidence showed the drug could increase risk of heart attack and stroke.
266812
Merck & Co. Inc. Chief Executive  Officer Raymond Gilmartin and FDA officials have been called to  testify before Congress on Nov. 18 over safety problems with  the company's withdrawn arthritis drug Vioxx, a top U.S.  lawmaker said on Wednesday.
104394
A top Republican lawmaker on Wednesday called on Merck &amp; Co. Inc. to answer questions about its withdrawn drug Vioxx at the first congressional hearing on Nov.
81161
Drug giant Merck pulled its painkiller Vioxx because it increased the risk of heart attacks and strokes. Now the company may face thousands of lawsuits.
226304
The announcement comes on the eve of a three-day FDA meeting called to discuss the safety of painkillers like Merck &#38; Co.
597746
Industry analysts are predicting US regulators this month will refuse to approve Merck &amp; Co.&#39;s new arthritis drug until at least 2006 because of heart attacks linked to its recalled sister drug Vioxx.
22491
Raymond Gilmartin, chief executive of Merck, will testify before a Senate committee this week on the withdrawal of Vioxx, in spite of efforts by the drug company to send others in his place.
675666
WASHINGTON -- After months of heightened concerns about the safety and effectiveness of Vioxx and similar best-selling painkillers, and intense criticism of how the Food and Drug Administration has handled them, the agency will launch critical meetings beginning tomorrow on what to do next.
174702
Hundreds of plaintiffs&#39; lawyers who say that people in the United States have been injured or killed by the painkiller Vioxx plan to meet in the coming week to lay groundwork for a nationwide legal drive against the drug&#39;s maker, Merck.
769773
TRENTON, N.J. -- Shares of drug maker Merck &amp; Co. dropped 2.5 percent in heavy trading yesterday, a day after medical journal reports offered fresh ammunition to patients suing over its withdrawn painkiller Vioxx.
501324
Justice Department prosecutors and Securities and Exchange Commission regulators are investigating Merck &amp; Co. for its handling of the painkiller Vioxx, the pharmaceutical giant disclosed yesterday.
177673
Hundreds of patients and physicians have contacted a special information line set up by Merck-Israel in the last few days after the international pharmaceutical company voluntarily withdrew Vioxx - one of the world&#39;s most popular arthritis and acute
497670
Oct. 11 issue - Last week Merck pulled its blockbuster arthritis-and-pain-relief drug Vioxx from the market. This week the 1.27 million Americans who were taking it are wondering what to do.
659314
A Brooklyn lawyer announced plans yesterday to file the first federal lawsuits against Merck &amp; Co. on behalf of New Yorkers who developed heart troubles using the arthritis drug Vioxx.
161742
Merck and Co. Inc. on Wednesday said a  federal court in Louisiana will handle pretrial matters in  product liability lawsuits around the country filed in federal  courts by former users of the company's withdrawn Vioxx  arthritis drug.
453647
The US Food and Drug Administration says it plans to convene a panel of experts in February to discuss the safety of painkillers in the same class as the now-withdrawn drug Vioxx.